Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hansoh Pharmaceutical Group Company Limited (HK:3692)
HKEX:3692
Hansoh Pharmaceutical Group Company Limited (3692) Stock Price & Analysis
1 Followers
3692 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$9.27 - HK$18.61
Previous CloseHK$15.98
Volume3.02M
Average Volume (3M)4.58M
Market Cap
HK$94.85B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)26.1
Beta1.17
Next Earnings
Aug 29, 2024EPS Estimate
HK$0.42Last Dividend Ex-Date
Jun 19, 2024Dividend Yield1.34%
Share Statistics
EPS (TTM)0.61
Shares Outstanding5,935,650,070
10 Day Avg. Volume4,640,000
30 Day Avg. Volume4,575,019
Standard Deviation0.09
R-Squared0.02
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$20.80Price Target Upside30.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Hansoh Pharmaceutical Group Company Limited News
PremiumCompany Announcements
Hansoh Pharmaceutical Awards RSUs to Employees
PremiumCompany Announcements
Hansoh Pharma Shareholders Unanimously Approve Resolutions
PremiumGlobal Markets
GSK Seeks to Strengthen China ConnectionsOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
2.64% Mutual Funds
1.81% Other Institutional Investors
95.55% Public Companies and
Individual Investors
3692 FAQ
What was Hansoh Pharmaceutical Group Company Limited’s price range in the past 12 months?
Hansoh Pharmaceutical Group Company Limited lowest stock price was HK$9.27 and its highest was HK$18.61 in the past 12 months.
What is Hansoh Pharmaceutical Group Company Limited’s market cap?
Currently, no data Available
When is Hansoh Pharmaceutical Group Company Limited’s upcoming earnings report date?
Hansoh Pharmaceutical Group Company Limited’s upcoming earnings report date is Aug 29, 2024 which is in 55 days.
How were Hansoh Pharmaceutical Group Company Limited’s earnings last quarter?
Hansoh Pharmaceutical Group Company Limited released its earnings results on Mar 26, 2024. The company reported HK$0.355 earnings per share for the quarter, beating the consensus estimate of HK$0.26 by HK$0.095.
Is Hansoh Pharmaceutical Group Company Limited overvalued?
According to Wall Street analysts Hansoh Pharmaceutical Group Company Limited’s price is currently Undervalued.
Does Hansoh Pharmaceutical Group Company Limited pay dividends?
Hansoh Pharmaceutical Group Company Limited pays a Annually dividend of HK$0.14 which represents an annual dividend yield of 1.34%. See more information on Hansoh Pharmaceutical Group Company Limited dividends here
What is Hansoh Pharmaceutical Group Company Limited’s EPS estimate?
Hansoh Pharmaceutical Group Company Limited’s EPS estimate is HK$0.42.
How many shares outstanding does Hansoh Pharmaceutical Group Company Limited have?
Hansoh Pharmaceutical Group Company Limited has 5,935,650,000 shares outstanding.
What happened to Hansoh Pharmaceutical Group Company Limited’s price movement after its last earnings report?
Hansoh Pharmaceutical Group Company Limited reported an EPS of HK$0.355 in its last earnings report, beating expectations of HK$0.26. Following the earnings report the stock price went up 1.096%.
Which hedge fund is a major shareholder of Hansoh Pharmaceutical Group Company Limited?
Currently, no hedge funds are holding shares in HK:3692
---
Hansoh Pharmaceutical Group Company Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
24.43%
12-Months-Change
Fundamentals
Return on Equity
13.40%
Trailing 12-Months
Asset Growth
7.99%
Trailing 12-Months
Company Description
Hansoh Pharmaceutical Group Company Limited
Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified, and leading drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on the gastrointestinal and cardiovascular therapeutic areas.
---
3692 Stock 12 Month Forecast
Average Price Target
HK$20.80
▲(30.16% Upside)
Technical Analysis
Best Analysts Covering 3692
1 Year
---